Form 4: AMN Healthcare CFO/COO Reports Stock Transactions
Insider Transaction Report
AMN Healthcare's CFO/COO, Brian M. Scott, reported the vesting of restricted stock units, subsequent tax-related share disposal, and the grant of new restricted stock units.
Summary
- Brian M. Scott, CFO/COO of AMN Healthcare Services Inc. (AMN), reported transactions on January 15, 2026.
- Acquired 8,843 shares of common stock upon the vesting of Restricted Stock Units (RSUs).
- Disposed of 3,592 shares of common stock at a price of $19.55 per share to cover tax obligations related to the RSU vesting.
- Received a new grant of 40,920 Restricted Stock Units (RSUs) under the AMN Healthcare 2025 Equity Plan.
- Following these transactions, Mr. Scott directly beneficially owns 13,093 shares of common stock and 81,840 Restricted Stock Units.
Sentiment
Score: 5
Explanation: The filing reports routine insider transactions related to executive compensation, including RSU vesting, tax withholding, and new RSU grants, which are neutral in terms of company performance.
Positives
- The vesting of 8,843 Restricted Stock Units represents a realization of previously granted equity compensation for the CFO/COO.
- The grant of 40,920 new Restricted Stock Units aligns the CFO/COO's long-term incentives with shareholder interests, demonstrating continued commitment to the company.
Negatives
- The disposal of 3,592 shares of common stock for tax purposes reduces the direct common stock ownership of the CFO/COO, although this is a standard practice for equity compensation.
Future Outlook
The new grant of Restricted Stock Units indicates a continued long-term incentive structure for the CFO/COO, with future vesting scheduled on the anniversaries of the January 15, 2026 grant date.
Industry Context
This filing represents a routine executive compensation event within the healthcare staffing and solutions industry, reflecting standard practices for equity-based incentives for senior management.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) as a component of executive compensation is a common practice across the healthcare and broader corporate sectors, aligning executive interests with long-term shareholder value.
- The withholding of shares for tax purposes upon RSU vesting is a standard mechanism, consistent with compensation practices at comparable companies in the S&P 500.
Stakeholder Impact
- Shareholders: The grant of new RSUs reinforces management's alignment with long-term company performance, potentially benefiting shareholder value.
- Employees (Executive): The transactions represent a standard component of executive compensation, reflecting the value of their service and future incentives.
Next Steps
- Future vesting of the 40,920 Restricted Stock Units granted on January 15, 2026, will occur in three tranches on the first, second, and third anniversaries of the grant date.
Key Dates
| Date | Description |
|---|---|
| 01/15/2025 | Grant date for 8,843 Restricted Stock Units, vesting in three tranches on the first, second, and third anniversaries of the grant date. |
| 01/15/2026 | Transaction date for RSU vesting, common stock acquisition, tax withholding, and new RSU grant. Also the grant date for 40,920 Restricted Stock Units, vesting in three tranches on the first, second, and third anniversaries of the grant date. |
Keywords
AMN Healthcare, AMN, Insider Trading, Form 4, Restricted Stock Units, RSU, CFO, COO, Equity Compensation, Stock Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.